Formulated with polygonum bistorta root (an anti-aging ingredient that addresses skin tone), wild rose extract (to refine ...

The FDA accepted Aldeyra's resubmitted NDA for reproxalap after previous rejections due to efficacy concerns, despite no ...

Multiple medications and treatments can be used to address dry eye and dry eye disease in patients, says Karen Fernandez, MD.

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...

Microplastics larger than 20 µm appear to be routinely present in commercially available eye drops, according to research published in Cornea. The investigation employed the use of micro-Fourier ...

The tool is designed to help with the application of mono-dose, dry eye eyedrop vials more easily and accurately.

The result was a notable drop in inflammation, with promising results in early models of sepsis and age-related macular degeneration. Related Stories ・Say goodbye to reading glasses: New eye drops are ...

The eye drops are used to treat symptoms experienced by nearly 4 million Americans following an increasingly common procedure.

The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned. The items affected were shipped May 26, 2023 through April 21, 2025.

Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23.

Nearly 76,000 cases of eye care products – including eye drops sold nationwide – have been recalled by their manufacturer.

Five different eye drop products that were sold between May 2023 and April 2025 were identified in a recall from manufacturer AvKARE.